GHK-Cu before and after, in short
Realistic topical GHK-Cu results look like this: barrier comfort within one to two weeks, smoother texture by week four, visible softening of fine lines from weeks four to eight, and measurable changes in firmness and wrinkle depth at eight to twelve weeks. In the strongest controlled trial available, an eight-week split-face study in 40 women aged 40 to 65, a GHK-Cu serum reduced wrinkle volume by 24.1% from baseline against 15.0% for the same serum without it (Badenhorst et al., 2016). Anything promising visible change in days is showing you lighting, a film-forming ingredient, or an injectable protocol.
This page is about GHK-Cu applied to the skin, which is where almost all of the published evidence is. Injectable protocols are covered briefly further down, but their evidence base is much thinner.
A note on the two numbers you will see everywhere. The copper peptide category quotes "55.8% wrinkle reduction" and "28% more collagen" constantly. Both figures are real, and both mean less than they sound like. We used to quote them the same careless way. The evidence section below shows what each one actually measured, because a number you can check is worth more than a number that flatters us.
| Timeframe | What changes | What is driving it |
|---|---|---|
| Week 1 to 2 | Barrier improvement, less dryness and tightness, calmer redness | Lipid carrier restoring the barrier; anti-inflammatory gene signaling begins |
| Week 2 to 4 | Better hydration and smoother texture; skin feels different before it looks different | Increased glycosaminoglycan synthesis in the dermis |
| Week 4 to 8 | Visible softening of fine lines, early firmness | New collagen fibers begin organizing into the dermal matrix |
| Week 8 to 12 | Measurable results: improved laxity, clarity, firmness and wrinkle depth | Leyden et al. 2002: 71 women with photoaging, 12 weeks of GHK-Cu facial cream |
| Beyond 12 weeks | No published trial has run longer than 12 weeks, so this is mechanism, not measurement | Pickart and Margolina gene data: a pattern of cumulative repair signaling |
If your skin looks worse rather than better in weeks two to four, that may be the adjustment phase people call the copper uglies. Our guide to GHK-Cu side effects has a week-by-week table for telling that apart from irritation.
If you have searched "GHK-Cu before and after," you have probably already scrolled past a dozen images that tell you nothing. Uncontrolled lighting. Different angles. Filters that magically vanished in the "after" shot. No timeframes. No product details. No explanation of what you are actually seeing.
That is not evidence. That is marketing.
The real before-and-after story of GHK-Cu copper peptide lives in published clinical research, where conditions are controlled and measurements are objective. That research is genuinely interesting. It is also smaller, shorter and more industry-funded than the marketing suggests, and knowing which is which is what separates someone who buys intelligently from someone who buys hopefully.
GHK-Cu clinical results: the measurable data
Let's start with what has actually been measured, and under what conditions.
Wrinkle volume and depth
Badenhorst et al. (2016), in the Journal of Aging Science, ran a randomized, double-blind, split-face trial in 40 women aged 40 to 65 over eight weeks. 39 completed it. Everyone applied a GHK-Cu nano-carrier serum to the right side of the face. Half (19 women) applied a Matrixyl 3000 product to the left side, and half (20 women) applied the same serum base with no GHK-Cu and no nano-carrier. Wrinkles were measured on one identified wrinkle near the corner of the eye with PRIMOS, a 3D stripe-projection imaging system.
Here is what it found, stated the way the paper's own tables state it:
| Measure, 8 weeks | GHK-Cu serum | Serum base, no GHK-Cu | Matrixyl 3000 product |
|---|---|---|---|
| Wrinkle volume, change from baseline | down 24.1% | down 15.0% | down 20.0% |
| Wrinkle depth, change from baseline | down 20.3% | down 15.3% | n/a in the same group |
| Relative improvement over the comparison side | n/a | 55.8% more volume reduction (p<0.01) | 31.6% more volume reduction (p=0.004) |
This is where the famous number comes from, and where it gets misread. The 55.8% is not a 55.8% shrinkage of anyone's wrinkles. It is how much more the GHK-Cu side improved than the plain serum side. The actual volume reduction was 24.1% against 15.0%. We stated it the wrong way for months, and so does most of the category. The same applies to the 32.8% depth figure, which is a relative improvement over the plain serum, not an absolute depth reduction.
The 31.6% figure against Matrixyl 3000 is correctly stated as a greater reduction than the comparator. Worth adding: the matching wrinkle depth comparison against Matrixyl 3000 did not reach statistical significance (23.4%, p=0.0577).
Three limitations the paper does not list, and should:
- It was funded by the maker of the tested serum. Snowberry New Zealand supplied the active product and the control, and the Matrixyl comparator was bought online. One author works for the contract lab that ran the trial.
- Forty women, eight weeks, one wrinkle each. That is a reasonable pilot, not a definitive result.
- The paper itself credits the nano-carrier, not the peptide. It states that the carrier, rather than the formulation, drove the wrinkle reduction. Since the test serum differed from the control by both the carrier and the GHK-Cu, the design cannot separate the two. We sell a tallow-based balm, not that nano-carrier serum, so this trial supports GHK-Cu as an ingredient worth formulating around. It does not transfer its numbers to our product or to anyone else's.
Collagen density: what the 28% figure really is
Correction, October 2026. This page used to say: "A study by Carey and Pickart using high-resolution ultrasound imaging tracked 21 subjects... the average increase in collagen density was 28%, and the top quartile saw 51%." Almost every part of that framing was wrong, and we are leaving the old wording here so you can see what changed.
What the 28% and 51% figures actually come from is a 2023 press release issued by Yuvan Research Inc., a California company, announcing results for its own GHK-Cu gel. The investigator named is Wayne Carey, MD, of McGill University. Loren Pickart, who discovered GHK-Cu in 1973, is not an author and had no stated role; naming him was our error. There is no published paper: no title, no journal, no volume, no DOI, and no trial registration we could find. The release says 21 women used the gel for three months and reports "an average of 28% increase in subdermal echogenic density (which correlates with collagen/elastin elements)," with the top quartile averaging 51%. No standard deviations, no confidence intervals, no p-values, and no control arm are given.
So: it is a company announcement about a company's own product, measuring an ultrasound proxy for collagen rather than collagen itself, with no peer review and no published data behind it. It may well be true. It is not evidence you should buy anything on, including ours.
Collagen production compared with other actives
Abdulghani et al. (1998) compared four topical creams on human skin over one month, with immunohistological analysis of skin biopsies. The reported results for procollagen synthesis are response rates, meaning the number of volunteers whose procollagen production rose at all:
- Copper-binding peptide cream: 7 of 10 volunteers
- Vitamin C cream: 5 of 10
- Melatonin cream: 5 of 10
- Tretinoin, a prescription retinoid: 4 of 10
This is the single most misquoted study in the copper peptide category. "70% more collagen than vitamin C" is not what it says. 70% is the share of volunteers who responded, not the size of anybody's increase, and the study tells us nothing about how much collagen any of them gained. With ten people per arm and one month of use, the gap between 7 of 10 and 4 of 10 is also well inside what chance can produce. It is a suggestive early result in copper peptide's favor and nothing more. We quoted it the wrong way round until September 2026, along with most of the industry.
The 12-week facial study
The 12-week facial trial people cite is Leyden et al., presented at the American Academy of Dermatology annual meeting in 2002. A GHK-Cu facial cream was applied for 12 weeks by 71 women with mild to advanced signs of photoaging. Reported improvements: increased skin density and thickness, reduced laxity, improved clarity, and reduced fine lines and wrinkle depth.
Two corrections to what this page said before. The number is 71, not 67, and no participant ages were ever published for it, so our old line about "women ages 50 to 59" was invented somewhere upstream and we repeated it. The study is also a conference abstract rather than a full peer-reviewed paper, which means the methods were never published in detail.
The related claim that GHK-Cu "strongly stimulated dermal keratinocyte proliferation" traces to a 2005 book chapter by Finkley, Appa and Bhandarkar, quoted in Pickart and Margolina's 2018 review. That is the published wording, and it is biologically muddled: keratinocytes sit in the epidermis, not the dermis. The mechanism claims that are cleanly supported in the same review are different ones: GHK-Cu increases integrin and p63 expression in epidermal basal cells, and increases collagen and elastin production in cultured human dermal fibroblasts at 0.01 to 100 nM.
This study still matters for the before-and-after question, because it used women with real photodamage rather than 25-year-olds with minor texture concerns. It just does not carry the precision that the number "67 women ages 50 to 59" implied.
GHK-Cu before and after: topical vs. injectable
This distinction matters because some of the most dramatic GHK-Cu claims online come from injectable protocols, and topical results follow a different timeline.
Topical GHK-Cu
This is what most people will use. Applied to the skin in a cream, serum, or balm formulation. All of the research above studied topical application.
Topical GHK-Cu works through the skin barrier, reaching dermal fibroblasts over time. Results build gradually. The data consistently shows measurable changes beginning around week 4 and becoming significant by week 8 to 12. The carrier matters: in the Badenhorst trial it was the carrier, not the peptide, that the authors credited with the wrinkle result. That is the reasoning behind formulating GHK-Cu into a lipid base rather than a water-based serum, which is why some copper peptide formulations use beef tallow as the carrier. Tallow is dominated by oleic, palmitic and stearic acid, the same three fatty acids that dominate human sebum. We used to put a percentage on that similarity. We removed it because we could not find a published comparison behind the figure.
Injectable GHK-Cu
Injectable copper peptide protocols (mesotherapy, microneedling with GHK-Cu solution) deliver the peptide directly into the dermis, bypassing the barrier entirely. Some practitioners report faster visible results because the active reaches fibroblasts immediately at higher concentrations.
However, injectable GHK-Cu is not FDA-approved for cosmetic use. Published clinical trials on injectable skin outcomes are limited. Most of the dramatic "before and after" images circulating from injectable protocols are from individual practitioners, not controlled studies. Be cautious with these claims. The mechanism is plausible, but the evidence base is not comparable to what exists for topical application.
If you see GHK-Cu before-and-after photos showing dramatic results in days or a week, those are almost certainly from injectable protocols, not from a cream. Topical results are real, but they follow biological timelines, not social media timelines.
Copper peptide results: a realistic week-by-week timeline
Based on the clinical data and consistent patterns across published studies, here is what topical GHK-Cu results actually look like over time. The table at the top of this page summarises the same timeline.
Week 1 to 2: Barrier improvement, reduced dryness and tightness. If your formulation includes a lipid carrier, this happens fast because the carrier itself is restoring the lipid barrier. The peptide's anti-inflammatory gene modulation also begins, which can reduce redness and irritation from previous products.
Week 2 to 4: Improved hydration and skin texture. The dermis begins retaining more moisture as glycosaminoglycan synthesis increases. Skin feels different to the touch before it looks different in a photo. This is the phase where most people decide if they are going to keep going or quit too early.
Week 4 to 8: Visible softening of fine lines. Early firmness improvement. In the Badenhorst trial, eight weeks was enough to measure a difference against a control serum on 3D imaging. If you are taking comparison photos (and you should, with consistent lighting and angles), this is when you will start to notice changes.
Week 8 to 12: Measurable results. This is the timeframe of the Leyden 12-week facial cream study: improved laxity, clarity, firmness and wrinkle depth in 71 women with photoaging. If someone asks you "does it work?" after 12 weeks, you should have a clear answer.
Beyond 12 weeks: Honestly, nobody has published a longer topical trial, so anything said about month four onwards is mechanism rather than measurement. What the gene data suggests is a pattern of continued repair signaling rather than the plateau and chronic sensitivity associated with long-term retinoid use. Pickart and Margolina (2018) report that GHK changes the expression of about 31.2% of the human genes profiled in the Broad Institute's Connectivity Map, by 50% or more in either direction, and read that as cumulative repair rather than diminishing returns. That is a reading of gene expression data, not a result anyone has measured on a face past week 12.
Why most "before and after" photos are useless
A brief note on visual evidence, because if you are searching for GHK-Cu before and after, you deserve to know how to evaluate what you find.
A valid before-and-after comparison requires: identical lighting (same source, same angle, same intensity), identical camera settings, identical distance from subject, no change in makeup or skincare layering, and a defined timeframe with a single variable changed. Clinical studies use devices like VISIA imaging systems or 3D profilometry to eliminate these variables entirely.
A photo taken in bathroom fluorescent light at 7am versus one taken in golden-hour window light at 5pm will make anyone's skin look "transformed" regardless of what product they used. This is not deception in most cases; it is just the reality of uncontrolled photography.
Instrument measurements are more reliable than any photo grid, because instruments do not care about lighting. But read them carefully. The three numbers this category quotes most often are a relative improvement over a control serum (55.8%), an unpublished company press release about a different product (28%), and a count of how many of ten volunteers responded at all (70%). None of them is a promise about your face.
Frequently asked questions
How long does GHK-Cu take to show results? Barrier and texture improvements appear within 2 to 4 weeks. Measurable wrinkle changes took 8 weeks in the Badenhorst split-face trial, and the 12-week Leyden facial cream study is where firmness, laxity and clarity improvements were reported.
Is GHK-Cu better than retinol for wrinkles? There is one small study that compared them directly, and it does not settle the question. In Abdulghani et al. (1998), 7 of 10 volunteers on a copper peptide cream showed increased procollagen synthesis against 4 of 10 on tretinoin, after one month. That is a response rate in ten people, not a measure of how much collagen anyone gained, and the difference is within what chance can produce. What can be said more confidently is that GHK-Cu does not cause the irritation, peeling and sun sensitivity associated with retinoids. For a deeper comparison, see our guide on copper peptides for aging skin.
Can I see GHK-Cu results in a week? Barrier repair and comfort, yes (especially with a tallow-based carrier). Structural collagen changes, no. Anyone showing dramatic wrinkle reversal in one week is either using injectable delivery, a film-forming agent for temporary visual tightening, or misleading photography.
What concentration of GHK-Cu works? No published trial has compared concentrations head to head in a finished cosmetic, so there is no honest answer in the form of a number. The Badenhorst trial's own conclusion points at delivery rather than dose: the carrier is what its authors credited with the result. GHK-Cu is also sensitive to breakdown by carboxypeptidase enzymes, so formulation and packaging matter. The HealthyDerm Blue Balm formulates GHK-Cu in a tallow base for that reason, which is a formulation rationale and not a claim that it outperforms anything in a trial.
Are GHK-Cu injectable results permanent? Injectable protocols are not FDA-approved for cosmetic use, and long-term data from controlled trials is limited. Topical maintenance is likely necessary regardless of initial delivery method, since the skin continuously turns over collagen.
If the research is what interested you, and you want a formulation built around the same ingredient, the HealthyDerm Blue Balm pairs GHK-Cu with methylene blue in a grass-fed tallow carrier designed for mature skin absorption.
References
- Badenhorst, T., Svirskis, D., Merrilees, M., Bolke, L., & Wu, Z. (2016). Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. Journal of Aging Science, 4(3), 1000166. Link. Funded by Snowberry New Zealand Ltd, the maker of the tested serum.
- Abdulghani, A. A., Sherr, S., Shirin, S., et al. (1998). Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin. Disease Management and Clinical Outcomes, 1(4), 136-141.
- Leyden, J., Stephens, T., Finkey, M., Appa, Y., & Barkovic, S. (2002). Skin Care Benefits of Copper Peptide Containing Facial Cream. Presented at the American Academy of Dermatology 60th Annual Meeting, New Orleans, LA, February 22-27, 2002, p. 68. Conference abstract, 71 women, 12 weeks.
- Finkley, M., Appa, Y., & Bhandarkar, S. (2005). Copper Peptide and Skin. In P. Elsner & H. Maibach (Eds.), Cosmeceuticals and Active Cosmetics: Drugs vs. Cosmetics (pp. 549-563). Marcel Dekker. Book chapter, source of the "dermal keratinocyte proliferation" wording.
- Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987. Link. Both authors are affiliated with Skin Biology, a copper peptide skincare company.
- Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015, 648108. Link
- Yuvan Research Inc. (2023, May 25). Epigenetic mechanisms activated by GHK-Cu increase skin collagen density. Press release, EurekAlert, filed as a Business Announcement. Link. Source of the 28% and 51% figures. Not a published study.
Revision history
October 5, 2026. Every statistic on this page was traced back to its source. Six things changed:
- The headline "55.8% reduction in wrinkle volume" was corrected. It is a relative improvement over a control serum. The actual reduction was 24.1% against 15.0%.
- The "28% collagen density increase, attributed to Carey and Pickart" was corrected. It is from a 2023 company press release about a different product, Loren Pickart is not an author, and it measured an ultrasound proxy rather than collagen.
- The 12-week facial study's details were corrected from "Finkley et al., 67 women ages 50 to 59" to Leyden et al. 2002, 71 women, ages never published.
- An unsourced claim that tallow is "roughly 55% identical to human skin sebum" was removed. We could not find a published comparison behind it.
- An unsourced pH stability range for GHK-Cu was removed.
- Study limitations, funding sources and author affiliations were added throughout, including our own commercial interest in the answer.
Danielle Dial
Glorious article. But how much GHK are you putting in your product? What %?